GAMCO INVESTORS, INC. ET AL - INTERSECT ENT INC ownership

INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 125 filers reported holding INTERSECT ENT INC in Q3 2021. The put-call ratio across all filers is 3.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
GAMCO INVESTORS, INC. ET AL ownership history of INTERSECT ENT INC
ValueSharesWeighting
Q1 2022$2,365,000
+10.3%
84,434
+7.5%
0.02%
+16.7%
Q4 2021$2,145,000
-0.6%
78,550
-1.0%
0.02%
-5.3%
Q3 2021$2,158,000
+137.9%
79,331
+49.5%
0.02%
+137.5%
Q2 2021$907,000
-20.4%
53,050
-2.7%
0.01%
-20.0%
Q1 2021$1,139,000
-20.5%
54,550
-12.8%
0.01%
-23.1%
Q4 2020$1,432,000
+47.5%
62,550
+5.0%
0.01%
+18.2%
Q3 2020$971,000
+147.1%
59,550
+105.3%
0.01%
+175.0%
Q2 2020$393,00029,0000.00%
Other shareholders
INTERSECT ENT INC shareholders Q3 2021
NameSharesValueWeighting ↓
KOPP INVESTMENT ADVISORS LLC 186,561$5,364,0004.51%
First Light Asset Management, LLC 517,121$14,867,0002.40%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,147,950$61,754,0002.21%
HealthCor Management, L.P. 1,950,000$56,063,0001.86%
PURA VIDA INVESTMENTS, LLC 200,000$5,750,0001.21%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 112,000$2,469,0001.17%
Broadfin Capital, LLC 234,200$6,733,0000.99%
Lombard Odier Asset Management (USA) Corp 240,000$6,900,0000.51%
PURA VIDA INVESTMENTS, LLC 83,527$2,401,0000.50%
Rock Springs Capital Management LP 460,000$13,225,0000.48%
View complete list of INTERSECT ENT INC shareholders